Impel Pharmaceuticals Inc.

IMPL · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$60,654$88,212$7,095$37,001
Short-Term Investments$0$0$0$0
Receivables$7,444$1,352$0$0
Inventory$8,427$2,824$0$0
Other Curr. Assets$3,284$2,188$1,077$2,524
Total Curr. Assets$79,809$94,576$8,172$39,525
Property Plant & Equip (Net)$6,995$3,149$3,700$2,740
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,746$187$187-$2,740
Total NC Assets$8,741$3,336$3,887$2,740
Other Assets$0$0$0$0
Total Assets$88,550$97,912$12,059$42,265
Liabilities
Payables$6,092$6,367$4,314$2,725
Short-Term Debt$1,541$0$417$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$3,173$0
Other Curr. Liab.$14,530$9,587$2,622$5,597
Total Curr. Liab.$22,163$15,954$10,526$8,322
LT Debt$49,645$29,450$7,994$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$60,899$0$127,039$0
Total NC Liab.$110,544$29,450$135,033$125,647
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$132,707$45,404$145,559$133,969
Equity
Pref Stock$0$97,912$127,039$125,647
Common Stock$24$23$0$6
Retained Earnings-$321,110-$214,798-$138,262-$92,464
AOCI$0-$97,912$0-$125,653
Other Equity$276,929$267,283-$122,277$252,060
Total Equity-$44,157$52,508-$133,500-$91,704
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$88,550$97,912$12,059$42,265
Net Debt-$9,468-$58,762$1,316-$37,001
Impel Pharmaceuticals Inc. (IMPL) Financial Statements & Key Stats | AlphaPilot